IT1247784B - Composizione e metodo per la riduzione dell'appetito - Google Patents

Composizione e metodo per la riduzione dell'appetito

Info

Publication number
IT1247784B
IT1247784B IT06792490A IT6792490A IT1247784B IT 1247784 B IT1247784 B IT 1247784B IT 06792490 A IT06792490 A IT 06792490A IT 6792490 A IT6792490 A IT 6792490A IT 1247784 B IT1247784 B IT 1247784B
Authority
IT
Italy
Prior art keywords
appetite
reduction
composition
Prior art date
Application number
IT06792490A
Other languages
English (en)
Other versions
IT9067924A1 (it
IT9067924A0 (it
Inventor
Richard J Wurtman
Timothy J Maher
Original Assignee
Interneuron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interneuron Pharma filed Critical Interneuron Pharma
Publication of IT9067924A0 publication Critical patent/IT9067924A0/it
Publication of IT9067924A1 publication Critical patent/IT9067924A1/it
Application granted granted Critical
Publication of IT1247784B publication Critical patent/IT1247784B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT06792490A 1989-11-28 1990-11-23 Composizione e metodo per la riduzione dell'appetito IT1247784B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/442,011 US5019594A (en) 1989-11-28 1989-11-28 Method for decreasing appetite

Publications (3)

Publication Number Publication Date
IT9067924A0 IT9067924A0 (it) 1990-11-23
IT9067924A1 IT9067924A1 (it) 1991-05-29
IT1247784B true IT1247784B (it) 1994-12-30

Family

ID=23755167

Family Applications (1)

Application Number Title Priority Date Filing Date
IT06792490A IT1247784B (it) 1989-11-28 1990-11-23 Composizione e metodo per la riduzione dell'appetito

Country Status (9)

Country Link
US (1) US5019594A (it)
JP (1) JPH03170421A (it)
KR (1) KR0173459B1 (it)
CA (1) CA2027815A1 (it)
CH (1) CH681959A5 (it)
DE (1) DE4037708A1 (it)
FR (1) FR2654932B1 (it)
GB (1) GB2238477B (it)
IT (1) IT1247784B (it)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096712A (en) * 1990-03-06 1992-03-17 Interneuron Pharmaceuticals, Inc. Method for enhancing performance so as to improve vigor and decrease fatigue, confusion, tension, and anxiety
US5527788A (en) * 1994-01-18 1996-06-18 Louisiana State Univ. Medical Center Foundation Method and composition for treating obesity comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent
FR2746644A1 (fr) * 1996-03-18 1997-10-03 Firion Jackie Produit parapharmaceutique moderateur d'appetit
JP2000515139A (ja) * 1996-07-17 2000-11-14 ニュートラコープ・サイエンティフィック・インク 食欲の抑制
US5795880A (en) * 1996-12-30 1998-08-18 Louisiana State University Medical Center Foundation Method and composition for treating obesity and related disorders in animals comprising dehydroepiandrosterone (DHEA), or a derivative thereof, and an anorectic agent
US5798101A (en) * 1997-01-22 1998-08-25 Hpf, L.L.C. Herbal appetite suppressant and weight loss composition
US5900418A (en) * 1997-02-10 1999-05-04 Synapse Pharmaceuticals International, Inc. Method for treatment of obesity
CA2288990A1 (en) * 1997-04-29 1998-11-05 Kenneth Blum, Inc. Allelic polygene diagnosis of reward deficiency syndrome and treatment
US6132724A (en) * 1998-04-29 2000-10-17 City Of Hope National Medical Center Allelic polygene diagnosis of reward deficiency syndrome and treatment
WO2001005356A2 (en) * 1999-07-20 2001-01-25 Natrol, Inc. Weight control product comprising a synergistic mixture of guggul extract, phosphate salt and metabolic stimulant
US6403657B1 (en) * 1999-10-04 2002-06-11 Martin C. Hinz Comprehensive pharmacologic therapy for treatment of obesity
US6759437B2 (en) * 1999-10-04 2004-07-06 Martin C. Hinz Comprehensive pharmacologic therapy for treatment of obesity including cysteine
US6719997B2 (en) 2000-06-30 2004-04-13 Dermatrends, Inc. Transdermal administration of pharmacologically active amines using hydroxide-releasing agents as permeation enhancers
US20030104041A1 (en) * 1999-12-16 2003-06-05 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
US6673363B2 (en) 1999-12-16 2004-01-06 Dermatrends, Inc. Transdermal and topical administration of local anesthetic agents using basic enhancers
US6602912B2 (en) 2000-06-30 2003-08-05 Dermatrends, Inc. Transdermal administration of phenylpropanolamine
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
JP2004534724A (ja) * 2000-11-01 2004-11-18 センション，インコーポレイテッド 記憶固化を調節するための方法および組成物
US20070117869A1 (en) * 2000-11-01 2007-05-24 Cognition Pharmaceuticals Llc Methods for treating coginitive impairment and improving cognition
US20050059743A1 (en) * 2000-11-01 2005-03-17 Sention, Inc. Methods for treating mild cognitive impairment and alzheimer's disease
US7619005B2 (en) * 2000-11-01 2009-11-17 Cognition Pharmaceuticals Llc Methods for treating cognitive impairment in humans with Multiple Sclerosis
US20030119884A1 (en) * 2000-11-01 2003-06-26 Epstein Mel H. Methods and compositions for regulating memory consolidation
US20030232890A1 (en) * 2000-11-01 2003-12-18 Sention, Inc. Methods for treating an impairment in memory consolidation
WO2002036077A2 (en) * 2000-11-06 2002-05-10 Andrx Pharmaceuticals, Inc. Once a day antihistamine and decongestant formulation
US20070293571A1 (en) * 2006-06-08 2007-12-20 Hinz Martin C Adminstration of dopa precursors with sources of dopa to effectuate optimal catecholamine neurotransmitter outcomes
WO2003079886A2 (en) * 2002-03-21 2003-10-02 Hinz Martin C Serotonin and catecholamine system segment optimization techonology
US20090311795A1 (en) * 2002-03-21 2009-12-17 Hinz Martin C Bilateral control of functions traditionally regulated by only serotonin or only dopamine
AU2003228603A1 (en) * 2002-04-22 2003-11-10 Rtc Research And Development, Llc. Compositions and methods for promoting weight loss, thermogenesis, appetite suppression, lean muscle mass, increasing metabolism and boosting energy levels, and use as a dietary supplement in mammals
CA2516653A1 (en) * 2003-02-21 2004-09-10 Martin C. Hinz Serotonin and catecholamine system segment optimization technology
EP1843819A2 (en) * 2004-11-15 2007-10-17 Obe Therapy Biotechnology S.A.S. Methods of reducing body fat
EP2074081A1 (en) * 2006-10-17 2009-07-01 Mallinckrodt Inc. Highly pure crystalline benzphetamine hydrochloride and processes for preparing
US20080221057A1 (en) * 2007-02-16 2008-09-11 Wyeth Secreted protein ccdc80 regulates adipocyte differentiation
EP2225261B1 (en) 2007-12-03 2016-03-09 Obe Therapy Biotechnology Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism
CA2922849A1 (en) 2012-08-31 2014-03-06 Ixchel Pharma, Llc Agents useful for treating obesity, diabetes and related disorders
US11344556B2 (en) * 2020-03-03 2022-05-31 Red Mountain Holdings, Llc Appetite suppressant compositions and methods thereof
US12310931B2 (en) 2023-02-21 2025-05-27 Red Mountain Med Spa, LLC Sublingual phentermine spray compositions and day-night appetite suppression and weight loss regimen using same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3445518A (en) * 1966-05-06 1969-05-20 Warner Lambert Pharmaceutical P-acylphenylethylamines
CH543479A (de) * 1970-05-06 1973-10-31 Hoffmann La Roche Verfahren zur Herstellung von Phenyläthylaminderivaten
US4327112A (en) * 1978-04-24 1982-04-27 Massachusetts Institute Of Technology Process for increasing blood pressure
US4598094A (en) * 1985-09-25 1986-07-01 Massachusetts Institute Of Technology Method and composition for enhancing the effect of indirect-acting sympathomimetic amines
US4673689A (en) * 1985-09-25 1987-06-16 Massachusetts Institute Of Technology Method and composition for enhancing the effect of indirect-acting sympathomimetic amines
US4885312A (en) * 1985-09-25 1989-12-05 Massachusetts Institute Of Technology Method for enhancing the effect of indirect-acting sympathomimetic amines

Also Published As

Publication number Publication date
IT9067924A1 (it) 1991-05-29
CA2027815A1 (en) 1991-05-29
GB2238477B (en) 1994-04-13
GB2238477A (en) 1991-06-05
CH681959A5 (it) 1993-06-30
GB9022173D0 (en) 1990-11-28
DE4037708A1 (de) 1991-05-29
JPH03170421A (ja) 1991-07-24
KR910009256A (ko) 1991-06-28
FR2654932A1 (fr) 1991-05-31
KR0173459B1 (ko) 1999-02-01
IT9067924A0 (it) 1990-11-23
FR2654932B1 (fr) 1993-08-13
US5019594A (en) 1991-05-28

Similar Documents

Publication Publication Date Title
IT1247784B (it) Composizione e metodo per la riduzione dell'appetito
IT1236831B (it) Apparecchio per il trattamento dell'intestino in particolare per enteroclisma
BR8803728A (pt) Composicao e metodo de revestimento
FI892718A7 (fi) Menetelmä alkoholismin hoidossa käytettävien farmaseuttisten koostumusten valmistamiseksi
DE68918943D1 (de) Gewebeentzusammensetzung und verfahren.
UA26853C2 (uk) Спосіб одержаhhя стабільhого соматотропіhу, стабільhий соматотропіh і композиція стабільhого соматотропіhу
IT8722783A0 (it) Procedimento di sintesi dell'amikacina
IT8522284A0 (it) Composizione moderatrice dell'appetito ed antigastrica.
FI894546A7 (fi) Menetelmä uusien 2'-halogeenimetylideeni-, 2'-etenylideeni- ja 2'-etynyyliadenosiinijohdannaisten valmistamiseksi
IT1175926B (it) Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenilalanina
DE68927221D1 (de) Schmierverfahren und Zusammensetzung dafür
DE69213415D1 (de) Elektroplattierungszusammensetzung und Verfahren
ZA909984B (en) Photosensitive resin composition and method of use thereof
ITMI931371A1 (it) Procedimento per la preparazione dell'erdosteina
BG90160A (bg) Метод за получаване на 4'-деметилепиподофилотоксин- глюкозиди
IT1197461B (it) Procedimento per la preparazione dell'estere metilico di alfa-l-aspartil-l-fenil-alanina
FI901316A7 (fi) Menetelmä 4(5)-imidatsolien valmistamiseksi
IT1226587B (it) Metodo per la produzione di veratrale e di altri alchil-aril-eteri similari
IT8467183A1 (it) Composizione farmaceutica per la profilassi ed il trattamento dell'arteriosclerosi.
KR880701792A (ko) 금속표면처리 조성물 및 처리방법
ITVE930025A0 (it) Metodo per effettuare radiografie dell'apparato stomatognatico ed ap- parecchiatura per attuare il metodo
IT1232783B (it) Metodo per l'alchilazione di gruppi guanidinici
ITMI912019A1 (it) Analoghi dell'irudina e procedimento per la loro preparazione
FI901317A7 (fi) Menetelmä uusien 4(5)-imidatsolien valmistamiseksi
IT8719390A0 (it) Composizione farmaceutica per la prevenzione e il trattamento dell'aterosclerosi.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971128